Enrolling By Invitation OBSERVATIONAL NCT06830226

Domperidone on the Composition of Preterm Breastmilk Using a Human Milk Mid-infrared Spectroscopy Analyzer (DompMilk)

The Effect of Domperidone on the Macronutrient and Energy Content of Breastmilk of Mothers With Preterm Delivery, Using a Human Milk Mid-infrared Spectroscopy Analyzer: a Study Protocol

Sponsor: Centro Hospitalar de Lisboa Central

Conditions Insufficient Breast Milk Syndrome Premature Birth

Interventions Reference group Test group

Updated 3 times since 2025 Last updated: Mar 14, 2025 Started: Jan 8, 2025 Primary completion: Jul 30, 2025 Completion: Aug 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Insufficient Breast Milk Syndrome and Premature Birth and is currently ongoing. Centro Hospitalar de Lisboa Central leads this study, which shows 3 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

3 versions recorded

Sep 2025 — Present [monthly]

Enrolling By Invitation
Apr 2025 — Sep 2025 [monthly]

Enrolling By Invitation
Mar 2025 — Apr 2025 [monthly]

Enrolling By Invitation

First recorded

Jan 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centro Hospitalar de Lisboa Central

Data source: Centro Hospitalar de Lisboa Central

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lisbon, Portugal